Literature DB >> 18827227

Generalized anxiety disorder severity scale validation in older adults.

Carmen Andreescu1, Bea Herbeck Belnap, Bruce L Rollman, Patricia Houck, Caroline Ciliberti, Sati Mazumdar, M Katherine Shear, Eric J Lenze.   

Abstract

OBJECTIVES: The Generalized Anxiety Disorder Severity Scale (GADSS) is a validated measure of Generalized Anxiety Disorder (GAD) symptom severity. Given the high prevalence of GAD in the elderly and the need for a validated scale to assess GAD severity in this age group, the authors examined the psychometric properties of the GADSS in the elderly. DESIGN, SETTING, PARTICIPANTS: The authors examined a sample of 134 elderly subjects (age 60 and above) who met diagnostic criteria for current GAD, 33 healthy elderly comparison subjects (age 60 and above) and 186 younger subjects (age 18-60) diagnosed with GAD.
RESULTS: The GADSS had a high internal consistency in the elderly subjects (raw Cronbach's alpha = 0.76). Pearson correlations showed a significant positive correlation between GADSS, Hamilton Rating Scale for Anxiety and Penn State Worry Questionnaire. Pearson correlations showed an inverse significant correlation between GADSS and the Medical Outcome Study SF-36. There was no correlation between GADSS and Mini Mental State Examination or Cumulative Illness Rating Scale for Geriatrics.
CONCLUSIONS: The results showed a good convergent, concurrent, and discriminant validity of the GADSS when used for elderly with GAD. The authors conclude that GADSS is a valid measure of GAD symptom severity in older adults.

Entities:  

Mesh:

Year:  2008        PMID: 18827227      PMCID: PMC2803316          DOI: 10.1097/JGP.0b013e31817c6aab

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  39 in total

1.  Cognitive errors, symptom severity, and response to cognitive behavior therapy in older adults with generalized anxiety disorder.

Authors:  Donald D Caudle; Ashley C Senior; Julie Loebach Wetherell; Howard M Rhoades; J G Beck; Mark E Kunik; A Lynn Snow; Nancy L Wilson; Melinda A Stanley
Journal:  Am J Geriatr Psychiatry       Date:  2007-08       Impact factor: 4.105

2.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

3.  Major depression and generalised anxiety disorder. Same genes, (partly)different environments--revisited.

Authors:  K S Kendler
Journal:  Br J Psychiatry Suppl       Date:  1996-06

4.  Characteristics of generalized anxiety disorder in older adults: a descriptive study.

Authors:  J G Beck; M A Stanley; B J Zebb
Journal:  Behav Res Ther       Date:  1996-03

5.  Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study.

Authors:  R L Spitzer; J B Williams; K Kroenke; M Linzer; F V deGruy; S R Hahn; D Brody; J G Johnson
Journal:  JAMA       Date:  1994-12-14       Impact factor: 56.272

6.  Testing a tripartite model: II. Exploring the symptom structure of anxiety and depression in student, adult, and patient samples.

Authors:  D Watson; L A Clark; K Weber; J S Assenheimer; M E Strauss; R A McCormick
Journal:  J Abnorm Psychol       Date:  1995-02

7.  Testing a tripartite model: I. Evaluating the convergent and discriminant validity of anxiety and depression symptom scales.

Authors:  D Watson; K Weber; J S Assenheimer; L A Clark; M E Strauss; R A McCormick
Journal:  J Abnorm Psychol       Date:  1995-02

8.  Generalized anxiety disorder in stroke patients. A 3-year longitudinal study.

Authors:  M Aström
Journal:  Stroke       Date:  1996-02       Impact factor: 7.914

9.  Major depression and generalized anxiety disorder. Same genes, (partly) different environments?

Authors:  K S Kendler; M C Neale; R C Kessler; A C Heath; L J Eaves
Journal:  Arch Gen Psychiatry       Date:  1992-09

10.  Anxiety disorders in later life: a report from the Longitudinal Aging Study Amsterdam.

Authors:  A T Beekman; M A Bremmer; D J Deeg; A J van Balkom; J H Smit; E de Beurs; R van Dyck; W van Tilburg
Journal:  Int J Geriatr Psychiatry       Date:  1998-10       Impact factor: 3.485

View more
  10 in total

1.  Latent dimensions of social anxiety disorder: A re-evaluation of the Social Phobia Inventory (SPIN).

Authors:  Laura Campbell-Sills; Emmanuel Espejo; Catherine R Ayers; Peter Roy-Byrne; Murray B Stein
Journal:  J Anxiety Disord       Date:  2015-09-18

2.  Cognitive-behavioral therapy for late-life anxiety: Similarities and differences between Veteran and community participants.

Authors:  Terri L Barrera; Jeffrey A Cully; Amber B Amspoker; Nancy L Wilson; Cynthia Kraus-Schuman; Paula D Wagener; Jessica S Calleo; Ellen J Teng; Howard M Rhoades; Nicholas Masozera; Mark E Kunik; Melinda A Stanley
Journal:  J Anxiety Disord       Date:  2015-05-07

3.  Brain structural changes in late-life generalized anxiety disorder.

Authors:  Carmen Andreescu; Dana Tudorascu; Lei K Sheu; Anusha Rangarajan; Meryl A Butters; Sarah Walker; Rachel Berta; Thomas Desmidt; Howard Aizenstein
Journal:  Psychiatry Res Neuroimaging       Date:  2017-08-17       Impact factor: 2.376

4.  The ages of anxiety--differences across the lifespan in the default mode network functional connectivity in generalized anxiety disorder.

Authors:  Carmen Andreescu; Lei K Sheu; Dana Tudorascu; Sarah Walker; Howard Aizenstein
Journal:  Int J Geriatr Psychiatry       Date:  2013-11-20       Impact factor: 3.485

5.  Disorder-specific impact of coordinated anxiety learning and management treatment for anxiety disorders in primary care.

Authors:  Michelle G Craske; Murray B Stein; Greer Sullivan; Cathy Sherbourne; Alexander Bystritsky; Raphael D Rose; Ariel J Lang; Stacy Welch; Laura Campbell-Sills; Daniela Golinelli; Peter Roy-Byrne
Journal:  Arch Gen Psychiatry       Date:  2011-04

6.  Altered cerebral blood flow patterns associated with pathologic worry in the elderly.

Authors:  Carmen Andreescu; James J Gross; Eric Lenze; Kathryn Dunfee Edelman; Sara Snyder; Costin Tanase; Howard Aizenstein
Journal:  Depress Anxiety       Date:  2011-03       Impact factor: 6.505

7.  Information processing bias and pharmacotherapy outcome in older adults with generalized anxiety disorder.

Authors:  Amanda R W Steiner; Andrew J Petkus; Hoang Nguyen; Julie Loebach Wetherell
Journal:  J Anxiety Disord       Date:  2012-11-21

8.  Alcohol use, anxiety, and insomnia in older adults with generalized anxiety disorder.

Authors:  M Cristina Ivan; Amber B Amspoker; Michael R Nadorff; Mark E Kunik; Jeffrey A Cully; Nancy Wilson; Jessica Calleo; Cynthia Kraus-Schuman; Melinda A Stanley
Journal:  Am J Geriatr Psychiatry       Date:  2013-08-20       Impact factor: 4.105

9.  Effectiveness of reboxetine in treatment of outpatient children and adolescents with attention deficit-hyperactivity disorder with comorbid anxiety disorders.

Authors:  Forough Riahi; Ashraf Tashakori; Sakineh Izadi-Mazidi; Mohammad Salehi-Veysi
Journal:  Iran J Psychiatry       Date:  2013-10

10.  A Randomized, Double-Blinded, Clinical Trial on Effects of a Vitis vinifera Extract on Cognitive Function in Healthy Older Adults.

Authors:  Gioacchino Calapai; Francesco Bonina; Andrea Bonina; Luisa Rizza; Carmen Mannucci; Vincenzo Arcoraci; Germana Laganà; Angela Alibrandi; Concetta Pollicino; Santi Inferrera; Umberto Alecci
Journal:  Front Pharmacol       Date:  2017-10-31       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.